Seroprevalence of human immunodeficiency virus type I (HIV-1) antibodies in a family-planning population.
Blind testing of 743 women who attended an inner-city hospital family-planning clinic showed 8 (1.1%) patients to have serum antibodies to human immunodeficiency virus type I (HIV-1). A retrospective chart survey did not show an association between HIV-1 antibody seropositivity and ethnicity, marital status, education, history of sexually transmitted diseases, drug and/or alcohol use, and contraceptive method. This failure to establish previously reported correlation may be a function of methods, sample size, or reflect a different population. Nonetheless, the seroprevalence the authors found shows that all patients in a family-planning clinic setting should be offered HIV-1 antibody testing.
Spence
M R
MR
Department of Obstetrics and Gynecology, Hahnemann University School of Medicine, Philadelphia, PA 19102.
Robbins
S M
SM
Polansky
M
M
Schable
C A
CA
D000328:Adult; D003267:Contraception / Q000379:methods; D003276:Contraceptives, Oral; D005193:Family Planning Services; D005260:Female; D015483:HIV Antibodies / Q000097:blood*; D015528:HIV Seroprevalence; D015497:HIV-1 / Q000276:immunology*; D006801:Humans; D015143:Philadelphia / Q000453:epidemiology; D012189:Retrospective Studies; D012307:Risk Factors; D012749:Sexually Transmitted Diseases / Q000150:complications / Q000453:epidemiology; D019966:Substance-Related Disorders / Q000150:complications
D003276:Contraceptives, Oral; D015483:HIV Antibodies